ArticleClinical epigenetics2025

TERT promoter methylation predicts overall survival, immune cell infiltration and response to immunotherapy in clear cell renal cell carcinoma.

Xinyu Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.